CAS Nr .: 1415456-99-3|Cagrilintide
Lub npe: Cagralintide
CAS Nr .: 1415456-99-3
Cov mis mos molecular:
Molecular Luj: 0
PIB: 206-141-6
MDL No.:
Product Description
Cagrilintide(CAS 1415456-99-}3) yog ib qho ua haujlwm ntev, acylated amylin analogue. Nws ua haujlwm raws li qhov tsis xaiv amylin receptor agonist (AMYRA) thiab calcitonin receptor agonist. Cov kab mob peptide no yog tsim los rau kev tshawb fawb tshawb fawb, tshwj xeeb hauv kev tswj hwm cov metabolism, tswj kev rog, thiab kev tshawb fawb glycemic tswj.
Technical Specification
| Khoom npe | Cagrilintide |
| CAS Nr | 1415456-99-3 |
| Synonyms | Cagrilintidum, N-epsilon-(19-carboxynonadecanoyl)-[(4-Acl)-Gly1,Gln14,Asn21,Pro37]-human-amylin |
| EINECS Number | 206-141-6 |
| Yam khoom | Peptide / Active Pharmaceutical Ingredient (API) Intermediate |
| Purity (HPLC) | Ntau dua lossis sib npaug li 98.0% |
| Qhov tshwm sim | Dawb kom tawm -dawb lyophilized hmoov |
Cov ntawv thov tshawb fawb
- Kev tshawb nrhiav Metabolic Syndrome:Tshawb nrhiav hauv kev sib koom ua ke- kev tshawb fawb txog kev tswj hwm nrog GLP-1 receptor agonists los ntsuas kev sib koom ua ke ntawm lub cev qhov hnyav.
- Amylin Receptor Signaling:Siv nyob rau hauv vitro thiab hauv vivo rau daim ntawv qhia mechanisms ntawm satiety signaling thiab gastric emptying retardation.
- Peptide Therapeutics Development:Ua haujlwm raws li tus qauv siv thiab lub tsev thaiv kev tshawb fawb ntev - ua cov qauv acylated peptide.
Kev tuav thiab khaws cia
Khaws cov hmoov lyophilized ntawm -20℃kom ntev -lub sij hawm ruaj khov. Tiv thaiv los ntawm lub teeb thiab noo noo. Rau cov kev daws teeb meem, muab faib rau hauv kev ua haujlwm aliquots thiab khaws cia hauv cov dej khov kom tiv thaiv kom khov-thaw degradation. Hnav cov cuab yeej tiv thaiv hauv chaw soj nstuam tsim nyog thaum tuav.
Cim npe nrov: cas 1415456-99-3|cagrilintide, Suav teb cas 1415456-99-3|Tuam Tshoj cagrilintide manufacturers, lwm tus neeg
